BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11095375)

  • 1. Correction of mesalazine-induced neutropenia with high-dose G-CSF.
    Bhidayasiri R; Katz JA; Sokos DR
    Am J Gastroenterol; 2000 Nov; 95(11):3321-2. PubMed ID: 11095375
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angioedema in Crohn's disease possibly due to mesalazine].
    Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
    Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
    [No Abstract]   [Full Text] [Related]  

  • 3. Mesalazine-induced aplastic anemia.
    Wiesen A; Wiesen J; Limaye S; Kaushik N
    Am J Gastroenterol; 2009 Apr; 104(4):1063. PubMed ID: 19259075
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesalazine-induced lupus.
    Timsit MA; Anglicheau D; Lioté F; Marteau P; Dryll A
    Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.
    Di Cesare A; Fidanza R; Riitano A; Fargnoli MC; Peris K
    Eur J Dermatol; 2011; 21(5):784-5. PubMed ID: 21697068
    [No Abstract]   [Full Text] [Related]  

  • 6. Asacol®-induced neutropenia resolution without the use of granulocyte colony-stimulating factor.
    Fowler BT; Gupta T; Bilal M
    South Med J; 2010 Nov; 103(11):1167-9. PubMed ID: 20859250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis.
    Frattini F; Crestani S; Vescovi PP; Franchini M
    Hematology; 2013 May; 18(3):181-2. PubMed ID: 23321335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mea culpa.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):409. PubMed ID: 18670441
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mesalazine is effective in Crohn disease].
    Quartarolo JP
    Ugeskr Laeger; 2005 Apr; 167(16):1767. PubMed ID: 15898611
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocarditis by mesalazine with cardiac magnetic resonance imaging.
    García-Ferrer L; Estornell J; Palanca V
    Eur Heart J; 2009 Apr; 30(8):1015. PubMed ID: 19168869
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia.
    Hung MJ; Wang CH; Cherng WJ
    Int J Clin Pract; 2002; 56(1):70-1. PubMed ID: 11831843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mesalazine is effective in Crohn disease 2].
    Quartarolo JP; Laegemidler F; Eskerod O
    Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mesalazine is effective in Crohn disease 1].
    Fallingborg J; Langholz E; Christensen LA; Munkholm P; Dahlerup JF
    Ugeskr Laeger; 2005 Mar; 167(11):1307-8; author reply 1309. PubMed ID: 15830509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mesalazine-induced acute pericarditis].
    Sierra Ausín M; Rascarachi G; Díez Rodríguez R; Arias Rodríguez L; Del Pozo Maroto E; Muñoz Núñez F
    Gastroenterol Hepatol; 2010 Apr; 33(4):338-9. PubMed ID: 20005014
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mesalazine is without clinical effect in patients with Crohn disease].
    Munck LK
    Ugeskr Laeger; 2005 Jan; 167(3):302-3. PubMed ID: 15704804
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M; Ikäheimo R; Pietiläinen T
    Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract]   [Full Text] [Related]  

  • 20. Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia.
    Kikkawa M; Matsubara S; Takatoku M; Kuwata T; Ohkuchi A; Izumi A; Watanabe T; Suzuki M
    J Obstet Gynaecol Res; 2008 Apr; 34(2):286-90. PubMed ID: 18412800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.